Introduction

Migrating clinical trial data from one Electronic Data Capture system to another is a complex process that requires careful planning, technical control, and regulatory oversight. Whether a sponsor is replacing outdated EDC software, consolidating systems after an acquisition, or moving studies to a more scalable platform, the migration must preserve the accuracy, completeness, consistency, and traceability of all study data.

A poorly managed migration can introduce missing records, altered values, broken audit trails, inconsistent coding, and reporting errors. For this reason, EDC migration should not be treated as a simple transfer of files. It is a controlled data transformation and validation exercise that affects clinical operations, data management, biostatistics, regulatory submissions, and inspection readiness.

Define the Migration Scope Before Moving Data

The first step is to clearly define what will be migrated. Depending on the study status and business requirements, the scope may include subject data, electronic case report forms, queries, audit trails, user information, site details, medical coding, laboratory data, attachments, signatures, and system configuration records.

Sponsors should also determine whether the migration involves an ongoing study, a completed study, or an entire clinical portfolio. Migrating an active study is usually more challenging because data continues to change while the migration is being planned and tested.

The migration plan should identify the source and target systems, data owners, responsibilities, timelines, validation activities, reconciliation procedures, and approval requirements. Experienced EDC software vendors should be able to support this planning process with documented migration methodologies and technical expertise.

Perform Detailed Data Mapping

Data mapping defines how information in the legacy system will appear in the new platform. Each field, form, variable, code, date format, status, and relationship must be mapped between the source and target environments.

This is particularly important when the two platforms use different database structures. A field stored as free text in the old data capture software may need to be converted into a controlled dropdown value in the new system. Similarly, subject identifiers, visit structures, units of measurement, and dictionary codes may require transformation.

The mapping document should explain every conversion rule and identify data that cannot be transferred directly. Any assumptions or exceptions should be reviewed and approved by clinical data management, quality assurance, and relevant study stakeholders.

Without accurate mapping, even a technically successful transfer can result in clinically misleading information.

Protect Original Data and Audit Trails

A core requirement of migration is ensuring that original data remains protected. The source database should be backed up and preserved before extraction begins. Access to the original system should also be controlled throughout the migration.

Reliable electronic data capture software must maintain traceability between the original and migrated records. The organization should be able to demonstrate where each value originated, whether it was transformed, who approved the transformation, and how the final result was verified.

Audit trails are especially important. They may contain the history of data entry, corrections, query responses, approvals, and electronic signatures. If the target system cannot reproduce the original audit trail format, the historical record should be retained in an accessible and reviewable archive.

This is essential for compliance with Good Clinical Practice, ALCOA+ principles, and applicable electronic records requirements.

Use Controlled Data Extraction and Transformation

Data extraction should be performed using approved scripts, reports, APIs, or validated export tools. Manual copying should be avoided because it increases the likelihood of omissions and transcription errors.

Before transformation, the extracted datasets should be reviewed for completeness. Record counts, subject counts, form counts, query counts, and key status fields should be documented. These baseline figures can later be compared with the migrated database.

During transformation, the migration team may need to standardize formats, convert codes, restructure visits, or resolve unsupported values. Every transformation should follow an approved rule. Unplanned data cleaning during migration should be avoided because it may make it difficult to distinguish a migration change from a clinical data correction.

Organizations using electronic data collection software should ensure that migration scripts are version-controlled, tested, reviewed, and executed in a controlled environment.

Validate the Target System Configuration

The target database must be ready before data is loaded. Forms, edit checks, visit schedules, roles, permissions, coding dictionaries, and integrations should be configured and validated.

The configuration should support the migrated data without changing its intended meaning. For example, if the source database permits partial dates, the target clinical trial data capture software must be able to represent those values correctly. If the new system applies different edit checks, the team should assess whether migrated records will generate unnecessary or misleading queries.

For ongoing studies, testing should also confirm that users can continue entering, reviewing, and cleaning data after the migration.

Conduct Multiple Test Migrations

A full migration should not be attempted without testing. Most projects require several dry runs using representative datasets.

The first test may focus on technical feasibility and basic field mapping. Later tests should cover complete subject records, unusual values, missing data, withdrawn subjects, unscheduled visits, medical coding, external data, and audit histories.

Teams working with electronic data capture software for clinical trials should test both common and exceptional scenarios. A migration may appear successful when standard records are reviewed, while uncommon records remain incomplete or incorrectly transformed.

Each test cycle should result in documented defects, corrective actions, updated mapping rules, and formal approval before the next stage begins.

Reconcile Source and Target Data

Reconciliation provides evidence that the migration is complete and accurate. It should include automated comparisons and targeted manual review.

Typical reconciliation checks include:

• Total number of subjects
• Number of forms and visits
• Missing and completed records
• Query status and history
• Coded terms
• Electronic signatures
• Key efficacy and safety variables
• Attachments and external data
• Audit trail availability

A risk-based approach may be used for detailed field-level verification, but critical data should receive greater attention. The clinical trial data collection software should support reports that make discrepancies easy to identify and investigate.

All differences must be explained. Some may be expected because of approved transformation rules, while others may indicate missing or altered data.

Control the Final Cutover

For an active study, the final cutover must be tightly coordinated. The organization may establish a temporary data entry freeze while the final extraction, transformation, loading, and reconciliation activities are completed.

Sites and study teams should receive clear instructions about system availability, pending data entry, open queries, and user access. A rollback plan should also be available in case the final migration fails.

The selected EDC clinical trial software should be prepared for production use only after validation results, reconciliation reports, deviations, and approvals have been reviewed.

Maintain Complete Migration Documentation

Migration documentation should include the migration plan, risk assessment, data mapping specifications, scripts, test evidence, discrepancy logs, validation reports, approvals, and final reconciliation results.

For organizations using EDC software clinical research teams must also document decisions about legacy system retention, archived audit trails, access controls, and long-term record availability.

Complete documentation allows sponsors to demonstrate that the data remained reliable throughout the transition. It also supports audits, inspections, database lock activities, and regulatory submissions.

Conclusion

This dailystorypro article must have given you a clear understanding of the topic. EDC system migration can be completed without compromising data integrity when it is managed as a controlled, validated, and fully documented process. Success depends on accurate data mapping, protected source records, tested transformation rules, careful reconciliation, and strong oversight.

The most effective clinical trial data collection software migration projects involve clinical data management, quality assurance, IT, statistics, operations, and regulatory teams from the beginning. By combining technical controls with risk-based validation and clear governance, sponsors can transition to a new platform while preserving the reliability, traceability, and regulatory value of their clinical trial data.